These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29871665)

  • 1. Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study.
    Bokore A; Korme B; Bayisa G
    BMC Pharmacol Toxicol; 2018 Jun; 19(1):28. PubMed ID: 29871665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of stavudine substitution due to toxicity in children receiving antiretroviral treatment in sub-Saharan Africa.
    Palmer M; Chersich M; Moultrie H; Kuhn L; Fairlie L; Meyers T
    AIDS; 2013 Mar; 27(5):781-5. PubMed ID: 23169331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motives for change of first-line antiretroviral therapy regimens in an unselected cohort of HIV/AIDS patients at a major referral centre in South-west Cameroon.
    Dimala CA; Bechem NN; Aroke D; Kadia BM
    BMC Res Notes; 2017 Nov; 10(1):623. PubMed ID: 29183354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia.
    Birlie B; Braekers R; Awoke T; Kasim A; Shkedy Z
    BMC Infect Dis; 2017 Jun; 17(1):453. PubMed ID: 28655306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda.
    Forna F; Liechty CA; Solberg P; Asiimwe F; Were W; Mermin J; Behumbiize P; Tong T; Brooks JT; Weidle PJ
    J Acquir Immune Defic Syndr; 2007 Apr; 44(4):456-62. PubMed ID: 17279048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stavudine toxicity in women is the main reason for treatment change in a 3-year prospective cohort of adult patients started on first-line antiretroviral treatment in Uganda.
    Castelnuovo B; Kiragga A; Kamya MR; Manabe Y
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):59-63. PubMed ID: 20861741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study.
    Anlay DZ; Alemayehu ZA; Dachew BA
    AIDS Res Ther; 2016; 13():10. PubMed ID: 26889204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the effect of Stalanev (Stavudine, Lamivudine and Nevirapine) treatment on plasma lactate levels in adults attending Beatrice Road and Wilkins Infectious Diseases Hospital Opportunistic Infections Clinics in Harare, Zimbabwe.
    Malunga G; Mujaji WB; Musarurwa C; Nyamayaro T
    Cent Afr J Med; 2012; 58(5-6):22-5. PubMed ID: 26255331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes for antiretroviral regimen change among HIV/AIDS patients in Addis Ababa, Ethiopia.
    Jima YT; Angamo MT; Wabe NT
    Tanzan J Health Res; 2013 Jan; 15(1):11-8. PubMed ID: 26591668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES).
    Lowe SH; Wensing AM; Hassink EA; ten Kate RW; Richter C; Schreij G; Koopmans PP; Juttmann JR; van der Tweel I; Lange JM; Borleffs JC
    HIV Clin Trials; 2005; 6(5):235-45. PubMed ID: 16306030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of adverse events to antiretroviral therapy in HIV- infected adults in Ekiti State, Nigeria.
    Popoola TD; Awodele O; Oshikoya KA
    Afr J Med Med Sci; 2016 Jun; 45(2):179-187. PubMed ID: 29465861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.
    Cournil A; Coudray M; Kouanfack C; Essomba CN; Tonfack CA; Biwolé-Sida M; Delaporte E; Bork K; Laurent C
    Antivir Ther; 2010; 15(7):1039-43. PubMed ID: 21041920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India.
    Saghayam S; Kumarasamy N; Cecelia AJ; Solomon S; Mayer K; Wanke C
    Clin Infect Dis; 2007 Jan; 44(2):295-300. PubMed ID: 17173234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
    Calmy A; Pinoges L; Szumilin E; Zachariah R; Ford N; Ferradini L;
    AIDS; 2006 May; 20(8):1163-9. PubMed ID: 16691068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Shanghai from 2006 to 2011.
    Shen Y; Wang J; Qi T; Wang Z; Lu H
    Int J STD AIDS; 2014 Jun; 25(7):504-10. PubMed ID: 24327726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of factors that influence antiretroviral regimen change and the subsequent patient outcomes at a Regional Hospital in rural KwaZulu-Natal.
    Soorju V; Naidoo P
    Afr J Prim Health Care Fam Med; 2016 Oct; 8(1):e1-e6. PubMed ID: 28155312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude and causes of first-line antiretroviral therapy regimen changes among HIV patients in Ethiopia: a systematic review and meta-analysis.
    Ataro Z; Motbaynor B; Weldegebreal F; Sisay M; Tesfa T; Mitiku H; Marami D; Teklemariam Z; Shewamene Z
    BMC Pharmacol Toxicol; 2019 Nov; 20(1):63. PubMed ID: 31675986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV patients presenting common adverse drug events caused by highly active antiretroviral therapy in Tanzania.
    Minzi OM; Irunde H; Moshiro C
    Tanzan J Health Res; 2009 Jan; 11(1):5-10. PubMed ID: 19445098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the magnitude and associated factors of immunological failure among adult and adolescent HIV-infected patients in St. Luke and Tulubolo Hospital, Oromia Region, Ethiopia.
    Bayou B; Sisay A; Kumie A
    Pan Afr Med J; 2015; 21():291. PubMed ID: 26587140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of antiretroviral therapy in HIV-infected adults in the Department of Haematology, University Hospital of Brazzavllle, Congo].
    Dokekias AE; Galiba FO; Bokilo AD; Ntsimba P; Nsitou MB; Malanda F; Basseila GB
    Bull Soc Pathol Exot; 2008 Apr; 101(2):109-12. PubMed ID: 18543703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.